Hims & Hers Health, Inc.
HIMS
Positions held
Your positionsHIMS isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- Hims & Hers operates in a growing telehealth market, which is expected to expand significantly as more consumers seek convenient healthcare solutions.
- Revenue increased by 24% compared to the prior quarter, reaching $753 million, indicating strong demand for their services.
- The company achieved a gross margin of 63.8%, demonstrating effective cost management despite previous fluctuations.
- The company faces intense competition in the telehealth space, which may pressure margins and market share.
- Hims & Hers reported a net income loss of $86.29 million in Q2 2026, reflecting ongoing profitability challenges.
- The operating margin remains negative at -12.9% for Q2 2026, highlighting the need for improved operational efficiency.
Fundamentals
| Market cap | $6.55B | Enterprise value | $7.25B | Trailing P/E | — | Forward P/E | 38.06 |
| PEG | 2.69 | Price / book | 20.20 | Beta | 2.43 | Dividend yield | 0.00% |
| Revenue growth | 38.2% | Earnings growth | — | Gross margin | 69.5% | Operating margin | -12.8% |
| Profit margin | -5.5% | ROE | -32.0% | ROA | -2.2% | Debt / equity | 4.77 |
| Current ratio | 0.93 | Free cash flow | $849.44M | Analyst recommendation | hold | Mean target | $31.15 |
| 52w high | $65.30 | 52w low | $13.74 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $753M | $608M | $618M | $599M | $545M |
| Op margin | -12.9% | -12.9% | 1.5% | 2.0% | 4.9% |
| Net income | -$86.3M | -$92.1M | $20.6M | $15.8M | $42.5M |
| Gross margin | 63.8% | 65.2% | 71.9% | 73.8% | 76.4% |
| Gross profit | $481M | $397M | $444M | $442M | $416M |
| Operating income | -$97.2M | -$78.3M | $9.2M | $11.8M | $26.7M |
- Revenue +24% vs prior quarter ($753M vs $608M).
- Gross margin 63.8% (was 65.2% prior quarter).
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $2.3B | $1.5B | $872M | $527M | — |
| Op margin | 4.5% | 4.2% | -3.4% | -13.0% | — |
| Net income | $128M | $126M | -$23.5M | -$65.7M | — |
| Gross margin | 73.8% | 79.5% | 82.0% | 77.6% | — |
| Gross profit | $1.7B | $1.2B | $715M | $409M | — |
| Operating income | $106M | $61.9M | -$29.5M | -$68.7M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · Is Hims & Hers Stock Ready For A Longer Cash Burn?
2026-10-08 · Why Hims & Hers Health, Inc. (HIMS) Dipped More Than Broader Market Today
2026-10-08 · Reasons to Retain Hims & Hers Stock in Your Portfolio for Now
2026-10-08 · Major Shuffle at Hims & Hers
2026-10-07 · Hims & Hers Health Names Jon Franklin as Chief Accounting Officer
2026-10-07 · Hims & Hers Names Jon Franklin as Chief Accounting Officer
2026-10-07 · Hims & Hers Health (HIMS) Investment Thesis: Capturing Market Share in the Cash-Pay Space
2026-10-07 · 3 Small-Cap Stocks on Our Watchlist
2026-10-06 · 2 Cash-Producing Stocks to Research Further and 1 We Find Risky
2026-10-05 · Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It
Price (daily)
Full chart · RSI · MACD · patterns